Techne’s stock price fell to $51.95. Shareholders have lost 13.8% of their capital, which is disappointing considering the ...
Earlier this week, Bio-Techne and Refeyn announced a first-of-its-kind integrated workflow that links Bio-Techne’s MauriceFlex™ icIEF fractionation system with Refeyn’s TwoMP mass photometry platform, ...
The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.
Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in ...
While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...
View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results